Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

414

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

February 28, 2007

Conditions
Lymphoma, Non-Hodgkin
Interventions
BIOLOGICAL

Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128)

treatment with 90 Yttrium-labeled anti CD 20 antibody

OTHER

no treatment

no treatment

Trial Locations (95)

1000

Brussels

1011

Lausanne

1211

Geneva

2020

Antwerp

2100

Copenhagen

3000

Leuven

3010

Bern

5000

Aarau

5530

Yvoir

6500

Bellinzona

8000

Bruges

8091

Zurich

9000

Ghent

9007

Sankt Gallen

10126

Torino

20089

Rozzano

20099

Hamburg

20122

Milan

20132

Milan

20141

Milan

25030

Besançon

28007

Madrid

28040

Madrid

29010

Málaga

33076

Bordeaux

35038

Rennes

37000

Tours

37007

Salamanca

37099

Göttingen

38043

Grenoble

40138

Bologna

40225

Düsseldorf

41685

Gothenburg

46010

Valencia

48129

Münster

49033

Angers

50924

Cologne

56126

Pisa

59037

Lille

59071

Hamm

67098

Strasbourg

69003

Lyon

69495

Pierre-Bénite

71013

San Giovanni Rotondo

72000

Le Mans

72076

Tübingen

75743

Paris

76038

Rouen

80131

Napoli

81675

München

86156

Augsburg

90146

Palermo

94010

Créteil

T6G 1Z2

Edmonton

V5Z 4E6

Vancouver

L8V 5C2

Hamilton

K1H 8L6

Ottawa

M4N 3M5

Toronto

M5G 2M9

Toronto

H1T 2M4

Montreal

H3A 1A1

Montreal

DK-8000

Aarhus

01309

Dresden

00144

Roma

3800 BM

Amersfoort

1081 HV

Amsterdam

Unknown

Amsterdam

5623 EJ

Eindhoven

7511 JX

Enschede

9713 GZ

Groningen

2333 ZA

Leiden

6229 HX

Maastricht

6500 HB

Nijmegen

3015 GD

Rotterdam

2545 CH

The Hague

3584 CX

Utrecht

8025 AB

Zwolle

0310

Oslo

N-9038

Tromsø

3000-076

Coimbra

1070-213

Lisbon

1649-035

Lisbon

4200-072

Porto

08907

L'Hospitalet de Llobregat

08025

Barcelona

08036

Barcelona

901 85

Umeå

S-751 85

Uppsala

G11 6NT

Glasgow

EC1A 7BE

London

NW3 2PF

London

M20 4BX

Manchester

NE1 4LP

Newcastle upon Tyne

PL6 8DH

Plymouth

SM2 5PT

Surrey

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY